476 related articles for article (PubMed ID: 28937318)
61. Farnesol abrogates epithelial to mesenchymal transition process through regulating Akt/mTOR pathway.
Lee JH; Chinnathambi A; Alharbi SA; Shair OHM; Sethi G; Ahn KS
Pharmacol Res; 2019 Dec; 150():104504. PubMed ID: 31678208
[TBL] [Abstract][Full Text] [Related]
62. CircRNA fibroblast growth factor receptor 3 promotes tumor progression in non-small cell lung cancer by regulating Galectin-1-AKT/ERK1/2 signaling.
Qiu BQ; Zhang PF; Xiong D; Xu JJ; Long X; Zhu SQ; Ye XD; Wu Y; Pei X; Zhang XM; Wu YB
J Cell Physiol; 2019 Jul; 234(7):11256-11264. PubMed ID: 30565694
[TBL] [Abstract][Full Text] [Related]
63. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
[TBL] [Abstract][Full Text] [Related]
64. Ribonucleotide reductase M2B inhibits cell migration and spreading by early growth response protein 1-mediated phosphatase and tensin homolog/Akt1 pathway in hepatocellular carcinoma.
Tian H; Ge C; Li H; Zhao F; Hou H; Chen T; Jiang G; Xie H; Cui Y; Yao M; Li J
Hepatology; 2014 Apr; 59(4):1459-70. PubMed ID: 24214128
[TBL] [Abstract][Full Text] [Related]
65. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
66. Ran GTPase induces EMT and enhances invasion in non-small cell lung cancer cells through activation of PI3K-AKT pathway.
Ning J; Liu W; Zhang J; Lang Y; Xu S
Oncol Res; 2013; 21(2):67-72. PubMed ID: 24406042
[TBL] [Abstract][Full Text] [Related]
67. miR-21 regulates growth and EMT in lung cancer cells via PTEN/Akt/GSK3β signaling.
Dai L; Chen F; Zheng Y; Zhang D; Qian B; Ji H; Long F; Cretoiu D
Front Biosci (Landmark Ed); 2019 Jun; 24(8):1426-1439. PubMed ID: 31136988
[TBL] [Abstract][Full Text] [Related]
68. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
69. The attenuation of epithelial to mesenchymal transition and induction of anoikis by gigantol in human lung cancer H460 cells.
Unahabhokha T; Chanvorachote P; Pongrakhananon V
Tumour Biol; 2016 Jul; 37(7):8633-41. PubMed ID: 26733180
[TBL] [Abstract][Full Text] [Related]
70. Gastrointestinal Factor GDDR Attenuates Epithelial-Mesenchymal Transition in Gastric Cancer via Inhibiting AKT Signal.
Fang C; Zhang Z; Liu C; Wang G; Wang F; Zhao Z; Li W; Hua J; Shuang J; Du J
Dig Dis Sci; 2016 Jul; 61(7):1941-9. PubMed ID: 27017226
[TBL] [Abstract][Full Text] [Related]
71. EML4-ALK induces epithelial-mesenchymal transition consistent with cancer stem cell properties in H1299 non-small cell lung cancer cells.
Guo F; Liu X; Qing Q; Sang Y; Feng C; Li X; Jiang L; Su P; Wang Y
Biochem Biophys Res Commun; 2015 Apr; 459(3):398-404. PubMed ID: 25735977
[TBL] [Abstract][Full Text] [Related]
72. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
73. α5-nAChR contributes to epithelial-mesenchymal transition and metastasis by regulating Jab1/Csn5 signalling in lung cancer.
Chen X; Jia Y; Zhang Y; Zhou D; Sun H; Ma X
J Cell Mol Med; 2020 Feb; 24(4):2497-2506. PubMed ID: 31930655
[TBL] [Abstract][Full Text] [Related]
74. Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism.
Phiboonchaiyanan PP; Kiratipaiboon C; Chanvorachote P
Chem Biol Interact; 2016 Apr; 250():1-11. PubMed ID: 26947806
[TBL] [Abstract][Full Text] [Related]
75. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
[TBL] [Abstract][Full Text] [Related]
76. HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.
Ruscetti M; Dadashian EL; Guo W; Quach B; Mulholland DJ; Park JW; Tran LM; Kobayashi N; Bianchi-Frias D; Xing Y; Nelson PS; Wu H
Oncogene; 2016 Jul; 35(29):3781-95. PubMed ID: 26640144
[TBL] [Abstract][Full Text] [Related]
77. Bone morphogenetic protein 2 mediates epithelial-mesenchymal transition via AKT and ERK signaling pathways in gastric cancer.
Liao A; Wang W; Sun D; Jiang Y; Tian S; Li J; Yang X; Shi R
Tumour Biol; 2015 Apr; 36(4):2773-8. PubMed ID: 25448881
[TBL] [Abstract][Full Text] [Related]
78. Placenta-specific protein 1 promotes cell proliferation and invasion in non-small cell lung cancer.
Yang L; Zha TQ; He X; Chen L; Zhu Q; Wu WB; Nie FQ; Wang Q; Zang CS; Zhang ML; He J; Li W; Jiang W; Lu KH
Oncol Rep; 2018 Jan; 39(1):53-60. PubMed ID: 29138842
[TBL] [Abstract][Full Text] [Related]
79. Preliminary mechanisms of regulating PD‑L1 expression in non‑small cell lung cancer during the EMT process.
Li F; Zhu T; Yue Y; Zhu X; Wang J; Liang L
Oncol Rep; 2018 Aug; 40(2):775-782. PubMed ID: 29901173
[TBL] [Abstract][Full Text] [Related]
80. Tripartite motif 16 inhibits epithelial-mesenchymal transition and metastasis by down-regulating sonic hedgehog pathway in non-small cell lung cancer cells.
Huo X; Li S; Shi T; Suo A; Ruan Z; Yao Y
Biochem Biophys Res Commun; 2015 May; 460(4):1021-8. PubMed ID: 25843803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
